The use and abuse of subgroup analysis in epidemiological research.

Most epidemiology involves the analysis of subgroups. In observational studies, identification of associations within particular subgroups is the usual method of investigation, while in experimental studies the purpose is to compare the rate of occurrence of the outcome of interest in treated and control groups. Problems can arise through failure to specify the subgroups of interest a priori and through examining large numbers of subgroups after the fact, i.e., through multiple testing. Rules for interpretation of findings in subgroups are suggested, and the value of the systematic application of criteria for judgement of the causal significance of any associations that may be observed is noted.

[1]  T. Takaro,et al.  Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. , 1977, The New England journal of medicine.

[2]  G. M. Paddle,et al.  GENETIC RISKS OF VINYL CHLORIDE , 1976, The Lancet.

[3]  W. S. Fields,et al.  Joint study of extracranila arterial occlusion. 3. Progress report of controlled study of long-term survival in patients with and without operation. , 1969, JAMA.

[4]  M. Collen,et al.  2. Disability and chronic disease after seven years of multiphasic health checkups , 1973 .

[5]  H. Falk,et al.  GENETIC RISKS OF VINYL CHLORIDE , 1976, The Lancet.

[6]  J. Platt Strong Inference: Certain systematic methods of scientific thinking may produce much more rapid progress than others. , 1964, Science.

[7]  M. Lipton,et al.  The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. , 1976, Circulation.

[8]  C. Fletcher,et al.  Smoking and health. , 1970, WHO chronicle.

[9]  H. Falk,et al.  GENETIC RISKS OF VINYL CHLORIDE , 1976, The Lancet.

[10]  V. Rønnov-Jessen Blood-volume and tolerance to pentolinium in the treatment of hypertension. , 1960, Lancet.

[11]  D. Labarthe,et al.  Methodologic variation in case-control studies of reserpine and breast cancer. , 1979, Journal of chronic diseases.

[12]  C. Joyce Rauwolfia derivatives and breast cancer: how do we know when we have the answers? , 1985 .